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Abstract
Individuals with urinary stone disease (USD) exhibit dysbiosis in the urinary tract and the loss of Lactobacillus that promote
urinary tract health. However, the microbial metabolic functions that differentiate individuals with USD from healthy individuals are unknown. The objective of the current study was to determine the microbial functions across prokaryotic, viral,
fungal, and protozoan domains that are associated with calcium oxalate (CaOx) stone formers through comparative shotgun
metagenomics of midstream, voided urine samples for a small number of patients (n = 5 CaOx stone formers, n = 5 healthy
controls). Results revealed that CaOx stone formers had reduced levels of genes associated with oxalate metabolism, as well
as transmembrane transport, proteolysis, and oxidation–reduction processes. From 17 draft genomes extracted from the data
and > 42,000 full length reference genomes, genes enriched in the Control group mapped overwhelming to Lactobacillus
crispatus and those associated with CaOx mapped to Pseudomonas aeruginosa and Burkholderia sp. The microbial functions
that differentiated the clinical cohorts are associated with known mechanisms of stone formation. While the prokaryotes most
differentiated the CaOx and Control groups, a diverse, trans-domain microbiome was apparent. While our sample numbers
were small, results corroborate previous studies and suggest specific microbial metabolic pathways in the urinary tract that
modulate stone formation. Future studies that target these metabolic pathways as well as the influence of viruses, fungi, and
protozoa on urinary tract physiology is warranted.
Keywords Shotgun metagenomics · Urinary microbiome · Urolithiasis · Oxalate metabolism · Urinary calculi · Calcium
oxalate
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Introduction
The rising prevalence of urinary stone disease (USD) worldwide over the last fifty years has not only resulted in significant patient morbidity due to high recurrent symptomatic
stone events [1], but also considerable burden to healthcare
systems, with annual costs of $10 billion in the US alone
[2]. The mechanisms that drive this increase in incidence
are unknown.
Evidence for a significant role of the human microbiome,
which contains all of the microorganisms present in or on the
human body, in the onset of urinary stone disease has rapidly accumulated in recent years [3]. Numerous studies have
linked the onset of kidney stones to past antibiotic use [4–6].
Additionally, metagenome-wide association studies, which
examine the human microbiome through molecular techniques, have found links between USD and the microbiome
[3]. There are clear and consistent signatures of a microbiome in non-infection stones themselves, acquired either
through molecular analysis and microbial culture techniques
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[4, 7], or biogeochemical techniques [8]. A recent comparative multi-omic clinical study found that the urinary tract
microbiome, but not the gut microbiome, defined cohorts
with either USD (excluding infection stone cases) or those
with no history of the disease [4]. These results implicate
the urinary tract microbiome, previously thought to be sterile
[9], as contributing more to the pathogenesis of USD than
the gut microbiota.
Metagenome-wide association studies of the urinary
tract microbiome have primarily utilized high-throughput
16S rRNA sequencing [4, 7, 10, 11], which provides a taxonomic survey of prokaryotic microorganisms in samples and
can be used for comparative analyses to determine if the
microbiome is associated with a particular clinical phenotype and quantify which specific taxa are significantly different between clinical cohorts. Few studies have examined the
metabolic potential of the urinary tract microbiome through
shotgun metagenomics [12, 13], which sequences the entire
metagenome of the microbial community in an untargeted
manner and allows for broader taxonomic resolution beyond
the prokaryotes, as well as a more in depth functional exploration of the microbiome. Therefore, the metabolic potential
of the urinary tract microbiome and how it relates to the
pathogenesis of urologic disease is largely unknown.
To gain a better understanding of the metabolic potential
and broader taxonomic profile of the urinary tract microbiome and how it relates to the pathogenesis of USD, we
performed, to our knowledge, the first comparative shotgun
metagenomic analysis of the urinary tract microbiome from
patients with either an active episode of USD with pure calcium oxalate (CaOx) stones or from patients with no history
of the disease. Based on past data, we hypothesized that the
microbiome of USD patients would harbor lower metabolic
diversity, and lower levels of Lactobacillus species in particular. Results of this analysis will help to elucidate the
contribution of the urinary microbiome to USD etiology,
with the potential to have broader implications for urologic
health.
Table 1  Patient demographic
data
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Methods
Participant recruitment
Following Institutional Review Board approval (IRB
# 16-643), patients that either had an active episode of
USD, in which patients were clinically diagnosed with
kidney stones as confirmed by imaging studies (ultrasound or non-contrast computed tomography; n = 5), or
no history of USD (n = 5), were prospectively identified
and recruited for study participation after informed consent was obtained by a trained clinical research coordinator. Participants in the USD group presented for care to
the Glickman Urological and Kidney Institute, Cleveland
Clinic, and were restricted to patients with an active presence of stones, prior to prophylactic antibiotic intervention, to remove potential biases associated with surgical
intervention or from being stone-free for a long period of
time. Control participants came from the broader population who responded advertisements placed throughout
Cleveland Clinic and had imaging to confirm they did
not have stones. To balance the potential for the alterations of the microbiome due to antibiotic use, this metric
was matched between groups at 30 days and 12 months
prior to sample collection. The number of participants
that used antibiotics in the last 30 days was low (n = 1
for each group). Stone composition was determined by
infrared spectroscopy. For the USD group, only individuals who had confirmed pure CaOx stones were used. Participants were asked to provide information relating to
biological sex, prior antibiotic use (past 30 days and past
12 months), age, personal history of USD, family history
of USD, co-morbidities, height, weight, and gastrointestinal illness (Table 1). It must be noted, that in a study of
this size, non-significant p values in clinical data do not
necessarily rule out potential confounders of the clinical indications. Data were collected through participant

Variable

Control

CaOx

p value

Statistic

No. enrolled
Age
% Female
Body mass index
% Prior USD
% Family history of USD
% Diabetic
% Hypertension
% Gastrointestinal illness
% Antibiotics used in past 30 days
% Antibiotics used in past 12 months

5
41 ± 19.59
40%
30.95 ± 4.1
0%
40%
0%
0%
20%
20%
40%

5
36.6 ± 10.87
40%
24.17 ± 1.65
40%
40%
0%
0%
0%
20%
60%

NA
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS

NA
Student’s t test
Relative risk, fisher exact test
Student’s t test
Relative risk, fisher exact test
Relative risk, fisher exact test
Relative risk, fisher exact test
Relative risk, fisher exact test
Relative risk, fisher exact test
Relative risk, fisher exact test
Relative risk, fisher exact test

Urolithiasis

questionnaires and medical chart review. Exclusion criteria included prior USD history (Control cohort only),
known history of chronic gastrointestinal disorders or urinary tract infections, < 18 years of age, urinary tract infection, infected stones (CaOx cohort only), and patients
with stones having a composition other than pure CaOx
(CaOx cohort only).

Urine collection and DNA extraction
Participants provided a midstream, voided urine sample of
at least 25 ml volume in the clinic, prior to any pre- or periprocedural antibiotics and prior to stone removal for the
CaOx group, following our IRB-approved protocol. Samples were preserved in boric acid prior to processing within
24 h of receipt. Prior to DNA extraction, urine samples were
centrifuged at 15,000 g for five minutes to pellet bacteria.

Fig. 1  Summary of the bioinformatic pipelines used in the current study
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◂Fig. 2  Taxonomic differences in the urobiome between CaOx and

Control patients. A All domains; *p value = 0.036; B Microbial
domains only; no significant differences were found; C-F Within
domain differences at the genus (Prokaryotes) or species level (Fungi,
Viral, Protozoa). Statistical differences for within domain comparisons are shown in Fig. 5

The DNA from the bacterial pellet was extracted using the
Urine DNA Isolation Kit for Exfoliated Cells or Bacteria
(Norgen; Thorold, ON, Canada), with modifications from
the manufacturer’s protocol, to include lysozyme, proteinase
K, and mutanolysin to bacterial pellets to facilitate bacterial
lysis, as previously described [4]. Negative controls included
preservation and DNA extraction reagents. Only samples
exhibiting a clear band on gel electrophoresis and with a
DNA concentration greater than 10 ng/μl were sent for shotgun metagenomic sequencing.

DNA sequencing and analysis
Extracted DNA was sent to Argonne National Laboratory
(Chicago, IL) for paired-end shotgun metagenomic sequencing on an Illumina HiSeq platform of 151 base pair segments. From the raw data, low quality reads were trimmed
and paired ends were merged using default parameters in
BBMerge [14]. Additionally, reads mapped to the human
reference genome (GRCh38), using BWA mem with default
settings [15], were removed. Paired, non-human, sequences
were pooled across samples and assembled in MetaSpades
with default parameters [16]. Resulting contigs were used
in pipelines to extract full-length genes for comparisons
between the Control and CaOx groups and to build draft
genomes de novo, as described below and presented in
Fig. 1.

Taxonomic profiling
To generate taxonomic profiles for each sample, non-host
sequence reads were mapped to a non-redundant database
containing 42,697 complete bacterial, archaeal, viral, fungal,
and protozoan genomes downloaded from the NCBI, using
BWA mem. Count tables of microbial communities were
then reduced to species or lowest assigned taxonomy for profiling and comparative analyses. To establish confidence in
taxonomic assignment, sequence homology was calculated
for each domain as a whole and for the most abundant taxa
by calculating the number of mismatched bases between the
sequenced DNA and the reference genomes.

Gene‑level profiling
Full-length microbial genes were extracted and annotated
from contigs using PROKKA [17]. Gene annotation was

achieved by mapping to the UniProt protein database. To
dereplicate genes, ensure common nomenclature across samples, and build a reference gene catalog for the quantification of gene counts, full-length genes were clustered at 90%
homology in CD-hit [18]. Subsequently, raw reads for each
sample were mapped to the high quality, annotated gene
catalog to generate gene-level count tables with BWA mem.

Comparative analyses
Raw count tables were normalized using the DESeq2
algorithm [19] and differential abundance analysis was
conducted with a negative binomial Wald test [19]. All p
values were false discovery rate (FDR) corrected for multiple comparisons with a cut-off at 0.05. Normalized count
tables were also used to generate a weighted Bray–Curtis
dissimilarity matrix in the Vegan R package, with statistical comparisons with a PERMANOVA at 999 permutations
[20] and estimates of taxonomic or genetic richness using
the “observed species” function in the Vegan R package,
with statistical comparisons generated by a paired t-test. To
determine which taxa and genes were differentially abundant
between groups, the DESeq2 algorithm was used with FDR
correction [19].

de novo genome construction
To determine which microbial taxa harbored the genes that
were significantly different between the Control and CaOx
groups, and thus help elucidate which taxa are important
for maintaining urologic health, we constructed microbial
genomes from the shotgun metagenomic data, de novo.
For the de novo construction of genomes, assembled contigs were binned to genomes with Autometa [21]. This
algorithm takes assembled contigs as input, bins the data
to genomes using contig coverage values, GC content, and
the Barnes-Hut t-Distributed Stochastic Neighbor Embedding (BH t-SNE) distribution of the contigs. Taxonomy is
assigned based on the consensus classification of all contigs
in a genomic bin. Completeness and purity calculations are
based on the presence of known, unique universal single
copy genes in Autometa.
After genomic binning, the contigs were oriented and scaffolded in CSAR [22], which compares the genomic bins to
reference genomes of close relatives. Gaps within the genomes
were filled with Abyss-Sealer [23] using raw sequencing reads
as input. The completeness and purity of genomes were recalculated and taxonomic assignment was validated through phylogenetic analysis of the de novo constructed genomes in comparison with all complete NCBI genomes, achieved through
Phylophlan, using the “—accurate” parameter which considers more phylogenetic positions at the cost of computational
speed [24]. Phylophlan allows for the phylogenetic analysis of
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Fig. 3  Sequence homology analysis. A Average sequence homology per domain. Each dot represents the average homology per sample. B
Sequence homology for specific taxa. Each dot represents the average sequence homology for a taxon within a single sample

bacteria and archaea using complete genomes rather than gene
amplicons, which provides greater resolution on phylogenetic
analysis.

Results
Patient characteristics
A total of 10 patients, 5 in each cohort, were recruited for
the current study. There were no significant differences
in past antibiotic use, age, prior instances of USD, diabetic status, hypertension, body mass index, sex, or gastrointestinal illness between the CaOx and Control group
(Table 1).

Shotgun metagenomic analysis and diversity
metrics
From 10 samples, over 305 million sequencing reads
were generated. After quality control and removal of
host-derived reads, 80.6 million reads remained. From
urine DNA samples, < 0.75% of reads overlapped with
stool samples from the same patients based on targeted
sequencing of the 16S rRNA gene [4]. There was a significant difference in the proportion of microbial reads
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retained, with proportionally more reads retained in
the CaOx group compared to Controls (Fig. 2A). After
sequence assembly and the extraction of full-length
genes, a total of 53,531 microbial genes were defined,
of which 27,884 were successfully annotated (52%).
Both the CaOx and Control groups were dominated by
Prokaryotes (Fig. 2B), with the Portiera and Klebsiella
as the dominant Prokaryotic genera (Fig. 2C). The fungal profiles were almost entirely comprised Malassezia restricta in both groups (Fig. 2D), while the BeAn
58,058 virus dominated the viral fraction (Fig. 2E). Protozoan profiles were dominated primarily by Plasmodium
vivax and Cyclospora cayetanensis (Fig. 2F). Sequence
homology was consistently above 98% for the fungal,
prokaryotic, and viral domains as a whole, while the
protozoan domain averaged between 93 and 96% homology compared to reference genomes (Fig. 3A). The most
abundant prokaryotes and fungi exhibited sequence
homology > 97%, while the most abundant viruses and
protozoa exhibited ~ 94% sequence homology with reference genomes (Fig. 3B).
The CaOx group exhibited significantly higher levels
of genetic diversity overall as determined by Margalef’s
index of the normalized counts of full-length genes
(Fig. 4A). In contrast, there were no differences in the
number of observed species for all taxonomic domains
combined, nor for individual domains (Fig. 4B-F).

Urolithiasis

Fig. 4  Genetic and species-level alpha-diversity between CaOx stone formers and controls. A Total genetic diversity; B All taxa combined; C
Prokaryotes; D Viruses; E Protozoa; F Fungi. Statistical analysis conducted as paired t tests
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◂Fig. 5  Metagenome

and species-level community composition
between CaOx stone formers and controls. A Total genetic diversity; B All taxa combined; C Prokaryotes; D Viruses; E Protozoa; F
Fungi. Statistical analysis conducted as a PERMANOVA with 999
permutations for a weighted Bray–Curtis dissimilarity matrix

The dissimilarity of the metagenomes between the
CaOx and Control groups was significant by genetic profile
(Fig. 5A), with greater within group dissimilarity among
the CaOx participants compared to the Controls (Figure
S1). The trans-domain profile was also significantly different between groups (Fig. 5B). These results were primarily
driven by differences in the Prokaryotic fraction of the
microbiome (Fig. 5C) rather than viral, protozoan, or fungal fractions (Fig. 5D–F). Differential abundance analysis
of taxa revealed a greater number of taxa enriched in the
CaOx group. However, the Lactobacillus enriched in the
Control group was the biggest single factor that differentiated the CaOx patients from the Controls (Fig. 6). A total
of one fungal species, three protozoans, and 20 viruses
differentiated CaOx from Controls (Fig. 6, Table S1).

Functional differences between Controls and CaOx
To determine the functional differences in the urinary tract
microbiome between the Control and CaOx groups, the
differential abundance of full-length genes was quantified.
From a total of 53,531 microbial genes, 3581 were enriched
in the Control group while only 303 were enriched in the
CaOx group (Fig. 7A). All significantly different, fully
annotated, microbial genes are presented in Table S2. The
primary metabolic pathways responsible for these differences include transmembrane transport, metal ion binding,
carbohydrate synthesis/metabolism, amino acid metabolism, zinc ion binding/transport, and oxidoreductase activity, all of which were higher in the Controls (Fig. 7B). In
addition to these pathways, we also identified the oxalatedegrading genes Oxalyl-CoA decarboxylase, Formyl-CoA
transferase, and Acetyl-CoA:Oxalate-CoA transferase in
the data. One copy each of the Oxalyl-CoA decarboxylase
and Formyl-CoA transferase was significantly higher in
the Control group compared to the CaOx group (Fig. 7B,
Table S2). Other pathways related to the synthesis, degradation, or transport of oxalate were also differentially abundant
between the two groups (Fig. 7B, Table S2).
A total of 17 genomes were constructed from the shotgun metagenomic data with completeness ranging from
17 to 98% and purity ranging from 89 to 100% (Fig. 8,
Table 2). Genomes are provided in Supplemental files 1–17,
with a summary of genome characteristics in Table S3.
Genomes were submitted to the NCBI under BioProject
#PRJNA717274. The taxa of the genomes were dominated
by Lactobacillus, with other taxa such as Burkholderia,

Pseudomonas, and Propionimicrobium known to comprise the urinary tract microbiome, also present (Table 2,
Fig. 8) [4, 7]. For the Controls, 687 of the 3581 significantly
higher genes (19%) mapped to L. crispatus de novo genome
(Table 2, Fig. 7C). However, the L. crispatus genome was
only 35% complete. When the significantly different genes
are mapped to full length reference genomes, the number
of Control genes mapped to L. crispatus increased to 1018
or 28.4% of the total (Figure S2, Table S2). The genes that
mapped to L. crispatus included the oxalate-degrading genes
that were higher in the Controls. In contrast, of the 303 genes
enriched in the CaOx cohort, most mapped primarily to an
unspecified Burkholderia (32 genes or 10.5%) and Pseudomonas aeruginosa (43 genes or 14.2%) based on the de
novo genomes. From reference genomes, 60 genes (19.8%)
mapped to Burkholderia contaminans and 40 (13.2%)
mapped to Portiera aleyrodidarum (Figure S2, Table S2).
Collectively, mapping significantly different genes to the
de novo constructed genomes accounted for 21% the genes
enriched in the Controls and 36% of the genes enriched in
the CaOx group. Interestingly, the P. aeruginosa also harbored 4 copies of an Acetyl-CoA:Oxalate-CoA transferase
gene, although these were not significantly higher in the
CaOx group.

Discussion
Recent metagenome-wide association studies focused on
urolithiasis have revealed links between this disease and
the human microbiome [3]. In the current study, we found
that CaOx stone formers had a significantly higher proportion of microbial reads and overall genetic diversity than
the Controls (Figs. 2A, 4A). These data suggest that there
was greater microbial load in the urinary tract of the CaOx
stone formers, even though none of the participants had a
history of urinary tract infections. Additionally, there was
a significant difference in metagenome, trans-domain, and
prokaryotic composition between the two groups overall
(Fig. 5A–C), which further elucidates the distinct microbial communities present within these groups. In contrast
to data showing greater microbial abundance in CaOx stone
formers, the Control group harbored a far greater number of
microbial genes enriched in the urine (Fig. 4A). These data
suggest that individuals with no history of urologic disease
harbor a core set of diverse bacteria that are consistently present in the urinary tract compared to CaOx patients, which
is corroborated by the fact that the CaOx had significantly
greater, within group variance in the metagenome dissimilarity (Figure S1). When a perturbation event occurs, such as
through the use of antibiotics, the urinary tract microbiome
can destabilize, leading to a loss of core bacteria, followed
by an overgrowth of a subset of the bacteria that are resistant
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◂Fig. 6  Differential abundance analysis across all domains, between

to the perturbation, which can eventually result in the onset
of urologic disorders. Numerous studies have independently
linked past antibiotic use to the onset of USD, with the urinary tract microbiome exhibiting a greater impact of antibiotics than the gut [4–6]. Thus, antibiotic use could provide
the mechanism of perturbance that leads to the urinary tract
dysbiosis.
Metabolic pathway analysis of the shotgun metagenomic data reveal several potential mechanisms about how
the urinary tract microbiome may contribute to the onset of
USD. Importantly, our study is the first to show that not only
are oxalate-degrading bacteria present in the urinary tract
(Table 2), but that oxalate-degrading genes are significantly
lower in the CaOx group (Fig. 7B). Additionally, pathways
associated with the metabolism of oxalate precursors, such

as ascorbic acid and glyoxylate, are also altered and suggests
that higher levels of these precursors could be present in
CaOx stone formers (Fig. 7B). Considerable attention has
focused on oxalate-degrading bacteria in the gut and their
role in USD [3]. However, our data indicate that the mitigation of oxalate by urinary tract bacteria may also play an
important role in USD pathogenesis.
Beyond oxalate, our data point toward the reduction of
microbial functions associated with other key pathways
known to be important mechanisms for stone formation
(Fig. 7B). These include transmembrane transport [25],
metal-ion binding and zinc binding in particular [26, 27],
carbohydrate synthesis/metabolism [28], and oxidoreductase
activity [29, 30]. Thus, many metabolic processes that have
been linked to stone formation may in part be influenced by
the urinary tract microbiome in a physiologically relevant
manner.
Taxonomic surveys, based on 16S rRNA surveys of the
urinary tract microbiome, have pointed toward bacteria such
as L. crispatus [4], Prevotella copri [4, 11], and Finegoldia
spp [10] as important species that differentiate healthy

Fig. 7  A Differential abundance gene analysis; B metabolic pathway
enrichment in terms of the number of microbial genes significantly
enriched in either the CaOx or Control group. Pathways were chosen
for inclusion if either a large number of significantly different genes

fit the pathway or the pathway had been previously associated with
urolithiasis. *Indicates pathways associated with oxalate metabolism,
synthesis, or transport; C Significantly difference genes mapped to de
novo constructed genomes

Caox and Control groups. Total number of taxa differing between
groups are listed in the x-axis in parentheses. Number of species
within each taxa enriched in either the CaOx or Control groups are
listed in the legend
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individuals from those with stones. In the current study, we
constructed multiple genomes, de novo, from the metagenomic data (Table 2). These genomes were taxonomically
annotated based on the consensus classification of multiple,
large contigs. The average size of our genomes was > 1.5
million base pairs (Table S3), which makes the taxonomic
classification far more robust than taxonomic assignment
from 300 base pairs or less. Confidence in the taxonomic
classification of our de novo constructed genomes and of
sequence reads can be assessed through our sequence homology analysis compared to reference genomes of the same
taxa (Fig. 3). By mapping genes associated with the Control
or CaOx cohorts to our de novo genomes, we found that 19%
of the Control-associated genes were attributed directly to
L. crispatus, which included the oxalate-degrading genes

enriched in the Control group. This number increased to
28.4% when the significantly different genes were mapped
to full length reference genomes. Additionally, a total of
24.7% of the CaOx-associated genes were attributed to a
Burkholderia sp. and P. aeruginosa based on our de novo
genomes. Reference genome analysis shows that (19.8%)
of CaOx genes mapped to Burkholderia contaminans and
40 (13.2%) mapped to Portiera aleyrodidarum (Figure S2,
Table S2). The L. crispatus species is known to be uroprotective and has successfully been used in clinical trials to
prevent recurrent urinary tract infections [31]. Given the
breadth of metabolic pathways associated to L. crispatus in
the current study, there are multiple potential mechanisms
that may contribute to this species’ uroprotective role. In
contrast, P. aeruginosa and Burkholderia spp. (formerly

Fig. 8  Phylogenetic tree of genomes constructed from shotgun metagenomic data of the urinary tract. Blue stars represent constructed genomes,
while the remaining datapoints were extracted from the microbial tree of life (Phylophlan)
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Pseudomonas) are known uropathogens that commonly
cause urinary tract infections [32]. Though none of the
patients in the current study had a clinical urinary tract
infection on standard urine culture, sub-clinical colonization by pathogenic bacteria may promote stone growth. This
hypothesis is corroborated by the documented presence of
other known uropathogens directly in non-infection kidney
stones, in the absence of clinical infections [4, 7].
The current study is the first to provide a trans-domain
microbial profile for the urinary tract. While non-Prokaryotic domains did not contribute much to the differentiation
of the Control and CaOx groups, some important results
must be considered. First, the fungal fractions were almost
entirely dominated by Malassezia restricta, while the viral

fractions were almost entirely dominated by a virus called
BeAn 58,058. The M. restricta is a common skin-associated
fungus and has also been found to be prevalent on the glans
of the penis [33]. Therefore, this dominant fungus is likely
a skin-contaminant of the microflora. In contrast, the BeAn
58,058 virus is a poxvirus originally isolated from a wild
rodent in Brazil [34] that has been found to be abundant
in the lungs [35], groundwater samples [36], and ocular
lymphomas [37]. However, this particular virus has high
sequence homology with the human genome and previous studies have attributed the finding of the BeAn 58,058
virus to be an artifact [35]. Finally, there were several protozoan species found in the urine samples, which were predominantly attributed to the Albugo candida, Cyclospora

Table 2  Summary of genome construction from shotgun metagenomic data. Included is the size of constructed genome, completeness
and purity of genome after the autometa and abyss-sealer steps, as

well as the number of oxalate-degrading genes and genes enriched in
either the control of CaOx groups that map to the genomes

Taxonomy

Size (bp)

Completeness Purity

NCBI taxid
(closest relative)

Oxalyl-CoA
decarboxylase

FormylCoA:oxalate
CoA-transferase

AcetylCoA:oxalate
CoA-transferase

Total no.
of Control
genes

Total no. of
CaOx genes

Actinotignum
sanguinis
Anaerococcus
vaginalis
Bifidobacterium breve
Burkholderia
Burkholderia
contaminans
Hafnia paralvei
Lactobacillus
crispatus
Lactobacillus
iners
Lactobacillus
iners
Lactobacillus
iners
Lactobacillus
iners
Propionimicrobium
lymphophilum
Pseudomonas
aeruginosa
Streptococcus
mitis
Tepidimonas
taiwanensis
Varibaculum
sp

711,869

36.43%

100%

1,445,614

0

0

0

6

0

648,911

52.14%

100%

33,037

0

0

0

16

2

2,246,848 97.86%

97.86% 1685

0

0

0

0

0

44,847
41.43%
3,990,717 34.23%

100%
32,008
97.96% 488,447

0
0

0
0

0
0

0
0

32
2

4,293,986 97.86%

99.27% 546,367

0

0

0

8

2

1,505,152 35%

100%

47,770

2

2

1

687

3

427,908

36.43%

100%

147,802

0

0

0

6

0

259,786

33.57%

100%

147,802

0

0

0

9

0

366,732

31.43%

100%

147,802

0

0

0

2

0

876,541

71.43%

100%

147,802

0

0

0

13

0

959,140

42.14%

96.70% 33,012

0

0

0

0

0

4,258,017 17.86%

89.29% 287

0

0

4

0

43

1,957,560 97.58%

98.56% 28,037

0

0

0

0

0

617,127

19.29%

100%

307,486

0

0

0

1

25

1,324,554 59.29%

100%

1,852,372

0

0

0

3

0
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cayetanensis, Diophrys appendiculata, and Plasmodium
vivax species (Figs. 2F, 3B). These protists include plant
pathogens, intestinal parasites, marine ciliates, and blood
parasites, respectively. Sequence homology analysis reveals
that the actual taxonomic assignment at the species level is
incorrect and instead the DNA of microorganisms found in
voided urine may actually represent more benign, closely
related species not well represented in public databases.
These related organisms may have been either ingested or
perhaps injected into the bloodstream by mosquitoes prior
to arriving in the urinary tract. Indeed, RNA and DNA is
well known to circulate in the bloodstream in exomes and
extracellular vesicles [38]. Though, the concept of “dietary
DNA” is controversial.
In conclusion, the present study provides additional
evidence that the urinary tract microbiome influences the
pathogenesis of USD, specifically driven by the loss of bacteria such as L. crispatus that may provide uroprotective
functions. Several metabolic pathways previously linked
to USD pathogenesis were attributed to the urinary tract
microbiome here and were significantly altered between the
Control and CaOx groups. Limitations of this initial exploratory study include small sample sizes and the fact that the
midstream voided urine samples reflect the lower urinary
tract rather than the upper urinary tract where stones form.
However, the lower urinary tract microbiome does not differ
from the lower urinary tract [7]. Additionally, given the clear
differences in the metagenome between CaOx stone formers
and healthy controls, along with the strong overlap between
differentiated pathways and those known to be involved with
stone formation, our results warrant further investigations
into the mechanistic roles that L. crispatus and the uropathogens Pseudomonas aeruginosa and Burkholderia play in the
pathogenesis of USD.
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